SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TELK -- Telik, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: zeta1961 who wrote (857)6/4/2007 5:28:34 PM
From: former_pgs  Read Replies (4) | Respond to of 887
 
>lthough I gotta give them some credit for presenting these to their colleagues[and Wall St.]<

I'm not so inclined.

Those results should have been disseminated immediately simply because the experimental arm did worse than standard of care.

How many patients would have enrolled in a telik trial after knowing that the drug was putting them at a disadvantage?

I think what they did was highly unethical.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News